Canopy Growth to Participate in Barclays Global Consumer Staples Conference on September 9, 2020
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announces that CEO David Klein, and EVP & CFO Mike Lee will be participating in a fireside chat at the Barclays Global Consumer Staples Conference on Wednesday, September 9, 2020 at 4:40pm ET.
Canopy Growth is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
The presentation will be conducted by live audio webcast, and will be accessible through the company’s website. A replay option will be available on the company’s website for those that cannot participate in the live event.
Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.